Penumbra, Inc.
PENStock
$319.60+33.97%52W
Market Cap$12.55B
P/E70.60x
Div yield—
Beta0.70
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-9.28%
Price vs S&P 500 (4W)-1.14%
VGM Score45.51
Market Capitalization$12.55B
P/E Ratio (Annual)70.60x
Earnings Surprise History
Q1 260.82est. 1.09
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
3.50
3.50
3.43
3.43
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
PENPenumbra, Inc. | F | C | B | $319.60 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| BAXBaxter International Inc. | B | F | C | $23.35 |
About
US-based Penumbra manufactures minimally invasive medical devices for mechanical removal of blood clots in acute care settings. The company's thrombectomy and embolization devices address stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular conditions, sold primarily to hospitals and physicians.